Switzerland-based drug manufacturer Novartis will be buying closely-held Massachusetts-based biotechnology firm so it will grow its range of immunotherapeutics products to treat cancer, Bloomberg reported.
Bio Tech
Biotech firm Thesan Pharmaceuticals closes $49M in Series B round
Thesan Pharmaceuticals, a biotech firm that develops therapies for skin conditions, raised $49 million for its Series B round led by existing investor Novo Ventures and joined in by SV Life Sciences, Lundbeckfond Ventures and Novartis Venture Fund.
UK-based Beringea invests £3M in Disposable Cubicle Curtains Limited
UK-based generalist investor Beringea has made a £3 million investment in anti-microbial curtains and blinds maker Disposable Curtains Limited which does business under the name All in One Medical.
Cancer Prevention and Research Institute of Texas awards $10.8M grant to biotech firm DNAtrix Inc
A $10.8 million product development grant was awarded to Houston-based DNAtrix Inc by the Cancer Prevention and Research Institute of Texas or CPRIT to fund its glioblastoma clinical stage program.
San Francisco-based Benchling offers DNA editing software for biotech labs, researchers
Benchling, a startup backed by YCombinator, SV Angel, Founders Fund, Draper Associates and other angels, bridges biotechnology and computer science with their DNA editing software.
Latest News
Berkeley, US-based biotech startup Exogen Biotechnology turned to crowdfunding to raise money for its DNA damage measuring technology amid shortage of venture capitalists investing in biotech firms.
Biotech companies are in a rush to go public partly due to the sky-high valuations now experienced by many biotech firms that have gone public in the past few years, the Venture Capital Dispatch reported.
Axine Water Technologies, an industrial wastewater treatment solutions provider, has secured $5.6 million for its Series A round from The Roda Group, Chrysalix Energy Venture Capital and BDC Venture Capital, TechVibes reported.
Rhenovia Pharma, biotechnology company that specializes in applying biosimulation in researching and developing new therapies, has secured $738,000 or €540,000 for its second financing round.
New York, US-based hedge fund Libra Advisors will pick up a $7.2% stake in Auckland, New Zealand-based business developer Rubicon to support that latter's future forestry biotech project.
Cambridge, Massachusetts-based firm MC10 made a bio-stamp that can take a person's vital signs and a head impact indicator backed by Reebok monitor for possible head trauma.
Ablynx, a Belgian biotechnology firm, has agreed to a €20 million deal with Merck to develop immunotherapies that can bolster the human body's potential to combat cancer cells, the Financial Times reported.
Life science startups of India, like Sea6 Energy which turns seaweed to biofuel, are taking on a higher level of risk in their goal of turning their research into successful businesses, The Economic Times reported.
Independent non-profit economic development organization Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) invested $2 million in 11 early-stage companies from the technology and life science sectors.
